Endovascular Treatment Decisions in Patients with M2 Segment MCA Occlusions

References

1. 1.↵
   1. Hartmann A,
   2. Rundek T,
   3. Mast H, et al

   . Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001;57:2000–05 doi:10.1212/wnl.57.11.2000 pmid:11739816

   Abstract/FREE Full Text
2. 2.↵
   1. Koton S,
   2. Tanne D,
   3. Green MS, et al

   . Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first National Acute Stroke Israeli Survey (NASIS 2004). Neuroepidemiology 2010;34:90–96 doi:10.1159/000264826 pmid:20016218

   CrossRefPubMed
3. 3.↵
   1. Paolucci S,
   2. Antonucci G,
   3. Grasso MG, et al

   . Functional outcome of ischemic and hemorrhagic stroke patients after inpatient rehabilitation: a matched comparison. Stroke 2003;34:2861–65 doi:10.1161/01.STR.0000102902.39759.D3 pmid:14615613

   Abstract/FREE Full Text
4. 4.↵
   1. Rai AT,
   2. Domico JR,
   3. Buseman C, et al

   . A population-based incidence of M2 strokes indicates potential expansion of large vessel occlusions amenable to endovascular therapy. J Neurointerv Surg 2018;10:510–15 doi:10.1136/neurintsurg-2017-013371 pmid:28963363

   Abstract/FREE Full Text
5. 5.↵
   1. Menon BK,
   2. Hill MD,
   3. Goyal M

   . Response by Menon to letter regarding article, “Analysis of workflow and time to treatment on thrombectomy outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) randomized controlled trial.” Circulation 2016;134:e406–07 doi:10.1161/CIRCULATIONAHA.116.024877 pmid:27821426

   FREE Full Text
6. 6.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T, et al

   . 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–10 doi:10.1161/STR.0000000000000158 pmid:29367334

   Abstract/FREE Full Text
7. 7.↵
   1. Menon BK,
   2. Hill MD,
   3. Davalos A, et al

   . Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES Collaboration. J Neurointerv Surg 2019;11:1065–69 doi:10.1136/neurintsurg-2014-011232

   Abstract/FREE Full Text
8. 8.↵
   1. Dorn F,
   2. Lockau H,
   3. Stetefeld H, et al

   . Mechanical thrombectomy of M2-occlusion. J Stroke Cerebrovasc Dis 2015;24:1465–70 doi:10.1016/j.jstrokecerebrovasdis.2015.04.013 pmid:25952748

   CrossRefPubMed
9. 9.↵
   1. Grossberg JA,
   2. Rebello LC,
   3. Haussen DC, et al

   . Beyond large vessel occlusion strokes: distal occlusion thrombectomy. Stroke 2018;49:1662–68 doi:10.1161/STROKEAHA.118.020567 pmid:29915125

   Abstract/FREE Full Text
10. 10.↵
    1. Coutinho JM,
    2. Liebeskind DS,
    3. Slater LA, et al

    . Mechanical thrombectomy for isolated M2 occlusions: a post hoc analysis of the STAR, SWIFT, and SWIFT PRIME studies. AJNR Am J Neuroradiol 2016;37:667–72 doi:10.3174/ajnr.A4591 pmid:26564442

    Abstract/FREE Full Text
11. 11.↵
    1. Sheth SA,
    2. Yoo B,
    3. Saver JL, et al

    . M2 occlusions as targets for endovascular therapy: comprehensive analysis of diffusion/perfusion MRI, angiography, and clinical outcomes. J Neurointerv Surg 2015;7:478–83 doi:10.1136/neurintsurg-2014-011232 pmid:24821842

    Abstract/FREE Full Text
12. 12.↵
    1. Saposnik G,
    2. Menon BK,
    3. Kashani N, et al

    . Factors associated with the decision-making on endovascular thrombectomy for the management of acute ischemic stroke. Stroke 2019;50:2441–47 doi:10.1161/STROKEAHA.119.025631

    CrossRefPubMed
13. 13.↵
    1. Samaniego E,
    2. Hasan D

    1. Roa JA,
    2. Martins SCO,
    3. Mont’Alverne FJ

    . Stroke care and mechanical thrombectomy in developing countries. In: Samaniego E, Hasan D, eds. Acute Stroke Management in the Era of Thrombectomy. Cham: Springer-Verlag; 2019;203–20
14. 14.↵
    1. Pandian JD,
    2. Sethi V,
    3. Dhillon R, et al

    . Is intravenous thrombolysis feasible in a developing country? Cerebrovasc Dis 2005;20:134–36 doi:10.1159/000086804 pmid:16006762

    CrossRefPubMed
15. 15.↵
    1. Emmett E,
    2. Wang Y, et al

    1. Stevens E

    , Emmett E, Wang Y, et al. The Burden of Stroke in Europe. London : Stroke Alliance for Europe; 2017
16. 16.↵
    1. Menon BK,
    2. Al-Ajlan FS,
    3. Najm M, et al

    . Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke. JAMA 2018;320:1017–26 doi:10.1001/jama.2018.12498 pmid:30208455

    CrossRefPubMed